CTGF is a Modifiable Mediator of Flow-dependent Atherosclerosis under Peripheral Artery Disease Conditions

1) Animal Handling

All mouse studies performed here were approved by the Institutional Animal Care and Use Committee (IACUC) at Emory University and under the established guidelines and regulations consistent with federal assurance. Fibulin-5 knockout (KO) [C57Bl/6 x 129S2/SvPas] mice were generated from a heterozygous breeding pair originally obtained from Dr. Hiromi Yanagisawa through MTA with UT-Southwestern.²⁶ Wild-type littermates were used as control. Constitutive endothelial cell (EC)-specific CTGF knockout (CTGF^fl/fl; Cdh5 Cre^+/-) mice were generated by breeding CTGF^fl/fl mice (generously provided by Dr. Andrew Leask) with transgenic Cdh5-cre^7Mlia mice (Jackson Lab). The CTGF^fl allele was converted to null allele by EC-specific Cdh5 Cre-mediated excision. ECWT^CTGF (CTGF^fl/fl; Cdh5 Cre^-/-) littermates were used as control group. The expression of Cre recombinase in endothelial cells was validated by breeding the Cre mice with Ai14 reporter mice (B6.Cg-Gt (ROSA)26Sortm14(CAG-tdTomato)Hze/J, Jackson Lab). ECKO^CTGF (CTGF^fl/fl; Cdh5 Cre^+/-) mice showed no difference in an initial clinical and biological analysis at baseline, including body weight and survival. Supplemental Figure 1 provides an overview of the animal experimental methodology and time points for arterial remodeling studies.

2) Partial Carotid Ligation Model of D-flow

In the partial carotid ligation model (PCL), three of the four caudal branches of the left carotid arteries (LCAs) were ligated as published,²⁸ resulting in a d-flow in LCAs.

Right carotid arteries (RCAs) were not manipulated and had stable flow (s-flow). PCL was performed on all mice groups as listed in Supplemental Figure 1. The in vivo hemodynamic environment in the carotid arteries was characterized at 2 and 4 weeks after PCL using ultrasonography. Blood pressure (BP) was assessed in all murine groups using the CODA noninvasive BP system (a tail-cuff method, Kent Scientific Corporation).

3) Biomechanical Testing of Arterial Stiffness

To compare the biomechanical properties, the carotid arteries were harvested from mice quickly after CO₂ asphyxiation, perfused with saline, isolated, excised, and frozen, prior to being mounted on an ex vivo bioreactor/biomechanical testing device for cylindrical biaxial biomechanical testing as published.²⁷

4) Endothelial Cell Function in vivo

Age and sex-matched KO and WT carotid arteries were isometrically mounted on wires, placed in an organ chamber containing Krebs-Henseleit buffer (pH is 7.4 when bubbled with 95% O2, 5% CO2 at 37 °C) and connected to a Harvard apparatus differential capacitor force transducer. For each carotid, tension was adjusted to 7.5 mN and then returned to a resting tension 5 mN that yielded maximal contractile response to 50 mM potassium chloride. Data are recorded using PowerLab digital acquisition and analyzed using Chart Software. Results are expressed as mean±SEM. Following precontraction with 2-5 μM phenylephrine, a concentration which yields 80-90% maximum contraction, relaxation responses were examined in response to methacholine (1 nM to 100 M), and the NO donor, sodium nitroprusside (SNP; 1 nM to 100 M). Relaxations were calculated as a percent of the pre-constricted tone induced by phenylephrine. Statistical analyses were performed by two-way ANOVA with Tukey’s post-test repeated measures.

5) EC-enriched RNA Isolation from Carotid Arteries

Total RNA from intima (EC-enriched) was collected from KO and WT LCAs and RCAs 24 hours post partial carotid ligation as published.⁷

6) Microarray Procedure, Data Analysis, and Bioinformatics

EC enriched RNA from 9 LCAs and 9 RCAs in KO animals were pooled for microarray analysis (n=3 using total of 9 mice per group). RNA sample quality was confirmed, and then samples were amplified and analyzed as a microarray using the MouseWG-6 v2 expression BeadChip array by the Emory Winship Cancer Genomics Core. The normalized microarray data was analyzed statistically, and the statistically significant genes that were differentially expressed genes (LCA vs. RCA) were screened for greater than 1.5 folds increase. The pathway enrichment analysis was performed by mapping these differentially expressed genes to GeneGO’s MetaCore™. This program functions as an integrated software suite for functional analysis of signaling pathways. GeneGO pathways were enriched by the 0.01 gene list derived from the EC-enriched microarray data. The meta-data was uploaded to the GEO Repository (GSE222583).

7) En face staining for EC Plasticity

Three days after LCA partial ligation, mice were euthanized by CO₂ inhalation and perfused with saline containing heparin, followed by a second perfusion with 10% formalin. LCA and RCA were carefully cleaned and dissected free of surrounding tissues and fats. LCA and RCA were en face stained with VE-cadherin antibody (BD Biosciences) and α-SMA antibody (abcam). LCA and RCA were counterstained using DAPI (Sigma) and mounted on glass slides using fluorescence mounting medium (Dako). En face images were collected with a Zeiss LSM 510 META confocal microscope.

8) Murine Model of Atherosclerosis

Atherosclerosis in left carotid arteries was induced in all murine groups using male and female mice aged 12-20 weeks old as published.²⁹

9) Histological and Immunohistochemical Analysis

Oil red O (ORO), H&E, Masson’s trichrome staining, and elastin autofluorescence were conducted on sections of common carotid arteries. Lipids were detected with ORO (Sigma) staining following the standard protocol as described.²⁸ Masson’s trichrome staining was used for the assessment of collagen composition of the atherosclerotic plaque. Elastin architecture was visualized by autofluorescence.

Immunohistochemical (IHC) staining of CD68 (BioRad) was applied to quantify macrophage positive area. The quantitative assessments of the arterial wall and necrotic area were blinded and quantified using Image J program. Each value was based on 3 replicates. Unpaired, two-tailed t-test was used to compare mean values of comparison d-flow carotid arteries with statistical significance at P<0.05.

10) Human Tissue Validation

Human artery samples from PAD and carotid endarterectomy (CEA) patients (Supplementary Tables 1 and 2) were collected from operative specimens after informed consent under an IRB approved protocol (Emory University approved IRB protocol numbers: 51432 and 70813). Arterial specimens were segregated prior to testing into d-flow conditions if there was not inline flow to the artery as validated and published prior⁷. In contrast, s-flow was defined in the same way as murine RCAs and attributed to arteries with inline flow to them. All d-flow arteries were in patients with proximal inflow occlusion and distal reconstitution through collateral pathways.

All s-flow arteries had inline flow without obstructive PAD.

11) CTGF Inhibition on Murine Atherosclerosis Model

The effects of CTGF inhibition on atherosclerosis development were examined through EC-specific CTGF knockout and CTGF monoclonal antibody (FG-3149) treatment in carotid atherosclerosis model. FG-3149 was generously donated to the Brewster laboratory by FibroGen Inc. (San Francisco, CA). Male ECWT^CTGF mice under atherosclerosis model were assigned to 2 antibody treatment groups: sham antibody (IgG; n=6) and FG-3149 (n=6). Antibodies were administered by intraperitoneal injection twice weekly at 30 mg/kg since day 1 after PCL for one month.

12) Statistics

Where not already stated, unpaired t-test were performed with GraphPad Prism (GraphPad Software). Parameters such as sample size, the number of replicates, the number of independent experiments, measures of center, dispersion, and precision (mean ± SD), and statistical significance are reported in figures and figure legends. Statistical significance was set at P<0.05.

KO carotid arteries mechanics

To compare KO and WT carotid arteries to PAD arteries, we used the ϕ_E (d-flow/s-flow ratio) of respective murine carotid artery elastic moduli and compared this to that of PAD arteries/aged healthy artery elastic moduli. Here, we found that KO arteries closely aligned with an approximately 3 fold stiffer ratio over physiologic mean pressures that was similar to that characterized in PAD arteries (Figure 1A). To identify the baseline stiffness of KO carotid arteries to that of aged control carotid arteries, we compared the compliance curves of unmanipulated KO arteries to 80-week old (∼18 months old) aged WT control mice arteries. Here we found that the compliance of unmanipulated (stable or s-flow) KO arteries were overall similar to aged WT arteries but even stiffer than aged control arteries from 60-80 mmHg (Figure 1B). To compare the impact of d-flow on KO carotid artery stiffening, we compared pressure-diameter and compliance curves of KO left carotid arteries (LCAs) exposed to d-flow to unmanipulated right carotid arteries (RCAs), which have stable flow (s-flow). After d-flow, KO LCAs underwent profound stiffening in the range of physiologic mean pressures, which is outlined by the box (Figure 1C, D). There were no differences in arterial stiffening in KO female versus male carotid arteries, regardless of flow conditions (Supplementary Figure 2). KO arteries had lower in vivo axial stretches (axial stiffening) with KO d-flow arteries the least compliant (Aged WT>KO RCA>KO LCA; Figure 1E). However, both KO RCAs and LCAs have robust residual stresses that are not further increased under d-flow (Figure 1F). PAD arteries have EC dysfunction. To test EC dysfunction in KO and WT arteries, EC-dependent and independent relaxation of KO and WT carotid arteries was performed. KO (but not WT) carotid arteries exhibited a basal EC dysfunction, indicated by impaired endothelial dependent vasodilation in arterial ring testing (Figure 1G) that was ameliorated by exogenous sodium nitroprusside (Figure 1H).

• Download figure
• Open in new tab

Figure 1:

Fibulin-5 Knockout (KO) Mimics the Hemodynamics and EC Dysfunction of PAD.

A. In order to compare relative biomechanical changes between wildtype (black line) and KO animal arteries (dotted line), an elastic modulus ratio was calculated from the left common carotid arteries (LCA exposed to d-flow) and the right common carotid arteries (RCA exposed to s-flow) over physiologic mean arterial pressures. We then calculated an elastic modulus ratio for PAD arteries compared to healthy arteries. Mean average ratio and standard deviation is superimposed as a triangle and blue line to the right of the curves. The KO artery ratio over physiologic mean pressures is greater than that of WT arteries and very similar to that of PAD arteries (blue triangle). B. To compare basal stiffness of KO carotid arteries to that of aged animals (80 weeks; ∼18 months), we compared s-flow KO RCA to that of aged mice. While most of the pressure ranges had similar stiffness, the KO RCA was stiffer than aged arteries from 60-80 mmHg. (KO n= 6-7; 4 males/3 females) C/D. To quantify flow-mediated stiffening in KO arteries, pressure-diameter and compliance curves were generated from biaxial testing to demonstrate that the d-flow KO carotid arteries were circumferentially stiffer than the contralateral s-flow RCAs.

E. To test longitudinal stiffening, aged arteries were compared to KO under s-flow and d-flow. Here there was sequential stiffening with d-flow KO least compliant. Symbols indicate statistical significance. F. Residual stress is a measurement of pathologic forces in the arterial wall. Opening angles in both KO RCA and LCA were exuberant but similar. G/H. To compare baseline endothelial cell dysfunction, endothelial cell dependent (G, N=6) and independent (H, N=6) relaxation was quantified via arterial ring testing. WT: 2 male, 4 female; KO: 3 male, 3 female. (B-D: Unpaired multiple t-tests with Holm-Sidak method; E: One-way ANOVA with Tukey’s post hoc test; G/H: Two-Way ANOVA with Tukey’s post hoc test (*p<0.05 compared to WT).

Validating d-flow environment/EC response to d-flow in KO carotid arteries

Next, the fidelity of the d-flow environment over the experimental time course was verified using duplex ultrasound (2/4 weeks). The RCA demonstrates s-flow with laminar WSS, whereas the LCA demonstrates low and oscillatory wall shear stress (Figure 2A-C). To identify early EC-enriched RNA pathways in KO arteries, we examined intimal RNA after 24 hours of d-flow. ECs on the d-flow, KO LCAs had significant downward expression of PECAM-1 and similar α-SMA levels (Figure 2D). By 72 hours of d-flow, en face staining of the intima demonstrates increased expression of α-SMA in the KO LCAs compared to d-flow WT LCAs (Figure 2H, F), as well as compared to both KO and WT RCAs, which were exposed to s-flow (Figure 2G, E). This induction of EC plasticity towards EndMT in KO + d-flow was verified in microarray pathway analysis and compared to that of d-flow, WT arteries (Figure 2I, J). Here the top 5 identified differentially expressed clusters in KO carotid arteries included cytoskeleton remodeling signaling pathways (including TGF and Wnt) along with the EndMT pathways. Venn diagram of microarray data comparing flow mediated differences within the KO and WT arteries identified only 24 overlapping genes, and 138 or 398 gene differences between the groups. This identifies disparate genetic fingerprints between the KO and WT arteries under flow (Supplementary Figure 3A, B; Supplementary Data File).

• Download figure
• Open in new tab

Figure 2: EC Plasticity in KO Carotid Arteries Under D-flow.

A/B. Representative duplex ultrasonography images of KO RCA and LCA two weeks after PCL. C. LCAs with d-flow manifest low and oscillatory WSS throughout the cardiac cycle (blue curve) compared to RCA (orange curve). D. 24 hours after PCL, intimal RNA expression of PECAM-1 was reduced in KO LCA endothelium compared to RCA. No significant change was observed in α-SMA and CD11b expression (D: Mean ± SD; unpaired t-test with significance set at P<0.05; n=3). E-H. En face immunofluorescence staining of the intima demonstrates robust α-SMA expression in the endothelium of KO LCAs (H) after 72 hours under d-flow. Scale bar: 50μm. I/J. Cluster pathway analysis identified differentially expressed genes (DEGs) in WT (I) and KO (J) arteries. Cell cycle and changes in the actin cytoskeleton predominated in the WT animals, while EndMT and TGF-beta/Wnt cytoskeletal remodeling was more prominent in KO consistent with cell stiffening and EC plasticity pathways.

KO carotid artery plaque under d-flow + atherogenic conditions

Since many of the identified fibro-inflammatory pathways that affect EC plasticity and arterial stiffening may also contribute to ASD plaque remodeling, an atherogenic environment was imposed on KO animals +/- d-flow; WT animals under the same conditions served as normal arterial compliance control animals. Histologic examination of carotid artery plaques was performed for weeks after induction of d-flow. Only LCAs under d-flow developed plaques; this occurred in both WT and KO animals. (Representative histology presented in Figure 3A-E) Here, pre-stiffened KO arteries demonstrated a more aggressive, vulnerable atherosclerotic plaque formation in response to d-flow. Specifically, KO LCAs had significantly more plaque area, lipid deposition in the plaque, percent necrotic area in the plaque, and macrophage content in the plaque (Figure 3F-I). KO arteries also had increased inner and outer diameter (Figure 3L-M), consistent with Glagov’s remodeling,³⁰ that correlated with an increase in elastin breaks (Figure 3N). In contrast, WT LCAs demonstrated a more fibrotic plaque phenotype with medial thickening and greater collagen content (Figure 3J, O-P). Atherogenic conditions did unmask an increase MAP in WT (compared to KO) male animals that did not exist under standard, non-atherogenic conditions (Supplementary Figure 4C, 3^rd panel). There were no differences in the serum lipid levels between KO and WT animals (Supplementary Figure 4E-L).

• Download figure
• Open in new tab

Figure 3: PAD Conditions (Stiff + D-flow) Induce Vulnerable Plaque Phenotype.

A-E. Representative images of Oil Red O (ORO), H&E, Masson’s trichrome, elastin autofluorescence and IHC staining of macrophages (CD68) of the LCA from WT and KO animals. F. KO LCAs showed significant larger atherosclerotic plaque burden. G. Lipid deposition within the plaques is higher in KO mice. H/I. Plaques in KO mice had increased necrotic area and greater macrophage infiltration. J/K. KO arteries had thinner medial layers than WT, but no difference in intima/media ratio. L/M. KO LCAs had increased inner and outer diameters of their lumen and arterial walls than WT. N. KO LCA also had increased elastin breaks compared to WT LCAs. O/P. In contrast, WT LCAs developed more collagen content in the plaque; collagen content in the rest of the arterial wall was similar. WT n=12 (7 males/ 5 females) and KO n=10 (5 males/ 5 females) in ORO quantification; WT n=8 (4 males/4 females) and KO n=7 (4 males/3 females) in the rest quantifications; male and female mice are represented with blue and pink symbols, respectively; data expressed as mean ± SD; unpaired t-test with significance set at P<0.05. Scale: 50 μm.

CTGF expression in response to aging and d-flow

When examining our WT and KO carotid artery gene expression data under d-flow, we found that CTGF was increased under d-flow and in KO compared to WT arteries. Specifically, and in a stair-step manner, CTGF was upregulated in d-flow WT LCAs compared to s-flow RCAs, and that s-flow KO RCAs had similar CTGF expression to that of d-flow WT LCAs. Further, CTGF expression increases in d-flow KO LCA compared to s-flow KO RCAs (Figure 4A). Since arterial stiffening and PAD is also associated with aging, we queried our young versus aged (18 months) murine s-flow/d-flow WT gene dataset to determine the impact of d-flow and aging on CTGF.³¹ We discovered a similar stair-step relationship for d-flow and aging in the upregulation of CTGF. Here, d-flow upregulates CTGF in young animal carotid arteries compared to s-flow, and older s-flow arteries have similar CTGF expression to that of younger d-flow arteries. Similarly, older d-flow carotid arteries had significantly greater CTGF expression (Figure 4B) than older, s-flow arteries.

• Download figure
• Open in new tab

Figure 4: CTGF Expression is Flow-mediated and Upregulated in Stiffened KO and Aged Murine Arteries and Under d-flow in PAD Arteries and Carotid Endarterectomy Specimens.

A. D-flow increases CTGF expression in LCAs. WT LCA and pre-stiffened, KO RCAs have similar CTGF expression levels, and CTGF is further increased in KO LCA compared to KO RCA. B. Similarly, CTGF expression is increased under d-flow in the LCA of young mice over that of s-flow RCAs, and to a similar degree as s-flow RCAs in old mice (80 weeks old). LCAs in older mice under d-flow is significantly increased over that of young d-flow and aged s-flow. C/D. The intima and rest of artery of both PAD arteries and CEA plaques under d-flow have increased CTGF deposition over that of aged healthy control arteries, respectively. E-G. Representative images of IHC staining of CTGF in healthy aged peripheral arteries, PAD arteries and carotid artery plaque. n=6 for healthy group; n=7 for PAD group; n=16 for CEA; mean ± SD; one-way ANOVA with Tukey’s post hoc test. Scale: 50 μm.

Prior to testing the modifiability of CTGF expression under PAD conditions, we validated the importance of CTGF in human PAD pathology. IHC staining for CTGF was quantified in d-flow PAD arteries and compared to aged infra-inguinal arteries under s-flow (patient information in Supplementary Table 1). To further test the role of d-flow on CTGF expression in vascular patients, we compared CTGF staining in carotid endarterectomy samples (patient information in Supplementary Table 2).

Here too, we found CTGF significantly upregulated both in the intima and remainder of the artery in PAD arteries and carotid endarterectomy samples compared to aged s-flow arteries (Figure 4C-G), establishing CTGF is increased under d-flow in PAD and carotid arteries.

Targeted CTGF therapies manipulate flow-mediated atherosclerotic plaques

To test the role of EC CTGF in flow-mediated atherosclerotic plaque biology, we created an EC-specific CTGF KO mice strain (ECKO^CTGF). We imposed atherogenic conditions in the same manner as prior (PCSK9 infection + high fat diet), then created d-flow by PCL. Male ECKO^CTGF mice developed less plaque burden and percent macrophage content in plaque under d-flow + atherogenic conditions compared to littermate control animals (Figure 5A, F, I). Female ECKO^CTGF mice developed a trend (P=.06) towards decreased necrotic area compared to littermate control animals (Supplemental Figure 5H) but were otherwise similar to control animals. To test the effect of CTGF inhibition with a monoclonal antibody (FG-3149; donated for research testing by Fibrogen, Inc.) as a translational therapeutic, male littermate WT control animals (ECWT^CTGF) under atherogenic conditions were treated with FG-3149 or control IgG antibody beginning on postoperative day 1 after PCL (induction of d-flow). Again, CTGF inhibition impacted flow-mediated carotid plaque. Specifically, plaque in d-flow LCA of animals treated with CTGF antibody (FG-3149) developed less lipid deposition and percent necrotic area in their plaques compared to IgG (Figure 6A, G-H).

• Download figure
• Open in new tab

Figure 5: Endothelial Cell CTGF Knockout (ECKO^CTGF) Decreases Plaque Area and Macrophage Infiltration in Male Mice Carotid Arteries Under D-Flow.

A-E. Representative images of Oil Red O (ORO), H&E, Masson’s trichrome, elastin autofluorescence and IHC staining of macrophages (CD68) of the LCAs from EC knockout of CTGF (ECKO^CTGF) and WT (ECWT^CTGF) animals. F. ECKO^CTGF mice have less atherosclerotic plaque area than control. G/H. Lipid deposition and necrotic area are similar between groups. I. ECKO^CTGF mice have less macrophage infiltration. J/K. ECWT^CTGF and ECKO^CTGF mice have similar medial thickness and intima/media ratio. L/M. The Inner luminal and outer arterial wall diameters of LCAs are similar between groups. N-P. There are no differences between groups in elastin breaks or the collagen content of the arterial intima or rest of arterial wall. ECWT^CTGF n=5; ECKO^CTGF n=5. Data expressed as mean ± SD; unpaired t-test with significance set at P<0.05. Scale: 50 μm.

• Download figure
• Open in new tab

Figure 6: CTGF Antibody (FG-3149) Decreases Lipid Content and Necrotic Area in Male Mice Carotid Arteries Under D-Flow.

A-E. Representative images of Oil Red O (ORO), H&E, Masson’s trichrome, elastin autofluorescence and IHC staining of macrophages (CD68) of the LCAs. F. FG-3149 treatment did not decrease atherosclerotic plaque area change. G/H. FG-3149 treatment decreased lipid accumulation and necrotic area. I. There was a trend towards decreased macrophage infiltration in the FG3149 treatment group. J/K. There were no differences in medial thickness or the intima/media ratio. L/M. There were no differences in the Inner luminal or outer arterial wall diameters between groups. N-P. There were no differences in elastin breaks or the collagen content within the intima or rest of arterial wall. IgG Sham antibody group n=6; FG-3149 group n=6; mean ± SD; unpaired t-test with significance set at P<0.05. Scale: 50 μm.

Targeted CTGF therapies improves arterial mechanics during flow-mediated remodeling

To test whether the effect of EC-specific CTGF knockout on artery stiffness, biaxial mechanical tests were applied to carotid arteries from ECWT^CTGF and ECKO^CTGF after 6 weeks of PCL under non-atherogenic conditions. Differences between LCA/RCA compliance curves are over a narrower pressure range in the ECKO^CTGF compared to ECWT^CTGF (Figure 7A, B). Similarly, animals treated with CTGF antibody (FG-3149) have similar differences, also over a narrower pressure range compared to IgG control arteries (Figure 7E, F). The axial stiffening of the ECWT^CTGF LCA compared to RCA trended towards significance (P=.05), whereas it did not (compliance more preserved) in the ECKO^CTGF LCAs (Figure 7C). Axial stiffness was significantly greater in IgG treated animals’ LCA compared to RCA, but not FG-3149 treated arteries, which were protected (Figure 7G). Moreover, under atherogenic conditions, the residual stresses of the ECKO^CTGF LCAs are significantly decreased compared to ECWT^CTGF LCAs (Figure 7D), supporting a favorable local impact on plaque mechanics.

• Download figure
• Open in new tab

Figure 7: CTGF Inhibition Improves Arterial Compliance During Disturbed Flow Mediated Arterial Remodeling.

A. Pressure-compliance curve of wild type (ECWT^CTGF) animals demonstrate decreased arterial compliance in LCAs under 10-80mmHg range (LCA n=4; RCA n=3; all male). Two-way ANOVA w/ Tukey correction. * p<0.05, [p=0.0006 p=0.0102 p<0.0001 p<0.0001 p<0.0001 p<0.0001 p<0.0001 p<0.0001] B. Pressure-compliance curves of ECKO^CTGF have a narrower range of pressures (10, 30-70 mmHg) that have a significant difference in arterial compliance between the LCA and RCA. (LCA n=3; RCA n=3; all male). Two-way ANOVA w/ Tukey’s posthoc *p<0.05 [p=0.028 p=0.0019 p<0.0001 p=0.0010] C. LCA from ECWT^CTGF trend toward significant axial stiffening as measured by axial stretch in the LCA versus RCA; axial compliance is preserved in ECKO^CTGF LCAs. One-way ANOVA w/ Tukey correction, nonsignificant. n=10, n=9, n=7 n=6 (RCA, LCA, KO-RCA, KO-LCA, respectively); p-values in figure. D. There were no differences in the opening angles between RCA and LCA in in the wild type (ECWT^CTGF: black/grey) or EC CTGF KO (ECKO^CTGF: purple and pink). Under atherogenic conditions, the wild type ECWT^CTGF animal has significantly greater residual stresses compared to ECKO^CTGF in the d-flow LCA. ECWT^CTGF RCA (n=27); ECWT^CTGF LCA (n=24); ECKO^CTGF RCA (n=15); ECKO^CTGF LCA (n=15); ECWT^CTGF LCA-plaque (n=20); ECKO^CTGFLCA-plaque (n=16). Ordinary one way ANOVA w/ Tukey’s correction, ECWT^CTGF LCA-plaque ECKO^CTGF LCA-plaque *p<0.0001 E. Pressure-compliance curves of carotid arteries from wild type (ECWT^CTGF) animals treated with sham IgG antibody demonstrate decreased arterial compliance in LCAs under 10-70mmHg range (LCA n=11; RCA n=11; 6 male/5 female). Two-way ANOVA w/ Tukey’s correction *p<0.05 [p=0.0283 p=0.0216 p<0.0001 p<0.0001 p<0.0001 p<0.0001 p<0.0001 p=0.0215] F. Pressure-compliance curves of carotid arteries from ECWT^CTGF treated with CTGF antibody (FG-3149) have a narrower range of pressures (40-80mmHg) that have a significant difference in arterial compliance between the LCA and RCA (LCA n=10; RCA n=10; 6 male, 4 female). Two-way ANOVA w/ Tukey’s correction *p<0.05 [p=0.0006 p<0.0001 p<0.0001 p=0.0008 p=0.0477] G. There is a significant difference in axial stiffening under d-flow (LCA) in the IgG treated animals. This is attenuated and not significant in the CTGF antibody (FG-3149) treated animals. RCA IgG n=11, LCA IgG n=10, RCA FG3149 n=10, LCA FG3149 n=10). Ordinary one-way ANOVA w/ Tukey’s correction. P value in figure.